How to buy Cronos Group (CRON) stock

Cronos Group Inc is a drug manufacturers-specialty & generic business based in the US. Cronos Group shares (CRON) are listed on the NASDAQ and all prices are listed in US Dollars.

Cronos Group stock price (NASDAQ: CRON)

Use our graph to track the performance of CRON stocks over time.

Cronos Group shares at a glance

• Key figures

Information last updated 2021-07-23.

Latest market close	$8.56
52-week range	$4.92 - $15.83
50-day moving average	$8.36
200-day moving average	$9.25
Wall St. target price	N/A
PE ratio	N/A
Dividend yield	N/A (0%)
Earnings per share (TTM)	$0.29

Buy Cronos Group shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.

*Signup bonus information updated weekly.

Is it a good time to buy Cronos Group stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

Technical Analysis of Cronos Group Inc by TradingView

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Cronos Group price performance over time

Historical closes compared with the close of $8.56 from 2021-06-03

1 week (2021-07-16)	N/A
1 month (2021-06-25)	-3.60%
3 months (2021-04-27)	4.26%
6 months (2021-01-23)	N/A

1 year (2020-07-23)	N/A
2 years (2019-07-23)	N/A
3 years (2018-07-23)	N/A
5 years (2016-07-23)	N/A

Cronos Group financials

Revenue TTM	$50.9 million
Gross profit TTM	$-25,833,000
Return on assets TTM	-5.51%
Return on equity TTM	-19%
Profit margin	0%
Book value	$4.23
Market capitalisation	$2.7 billion

TTM: trailing 12 months

Shorting Cronos Group shares

There are currently 20.9 million Cronos Group shares held short by investors – that's known as Cronos Group's "short interest". This figure is 3.5% down from 21.7 million last month.

There are a few different ways that this level of interest in shorting Cronos Group shares can be evaluated.

Cronos Group's "short interest ratio" (SIR)

Cronos Group's "short interest ratio" (SIR) is the quantity of Cronos Group shares currently shorted divided by the average quantity of Cronos Group shares traded daily (recently around 3.0 million). Cronos Group's SIR currently stands at 7.05. In other words for every 100,000 Cronos Group shares traded daily on the market, roughly 7050 shares are currently held short.

However Cronos Group's short interest can also be evaluated against the total number of Cronos Group shares, or, against the total number of tradable Cronos Group shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cronos Group's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Cronos Group shares in existence, roughly 60 shares are currently held short) or 0.1067% of the tradable shares (for every 100,000 tradable Cronos Group shares, roughly 107 shares are currently held short).

A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Cronos Group.

Find out more about how you can short Cronos Group stock.

Cronos Group share dividends

We're not expecting Cronos Group to pay a dividend over the next 12 months.

Cronos Group share price volatility

Over the last 12 months, Cronos Group's shares have ranged in value from as little as $4.915 up to $15.83. A popular way to gauge a stock's volatility is its "beta".

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Cronos Group's is 1.8028. This would suggest that Cronos Group's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Cronos Group overview

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc.

Frequently asked questions

What percentage of Cronos Group is owned by insiders or institutions?
Currently 47.233% of Cronos Group shares are held by insiders and 16.856% by institutions. When does the fiscal year end for Cronos Group?
Cronos Group's fiscal year ends in December. Where is Cronos Group based?
Cronos Group's address is: 111 Peter Street, Toronto, ON, Canada, M5V 2H1 What is Cronos Group's ISIN number?
Cronos Group's international securities identification number is: CA22717L1013 What is Cronos Group's CUSIP number?
Cronos Group's Committee on Uniform Securities Identification Procedures number is: 226903102